Tower Research Capital LLC (Trc) Neuro Pace Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Neuro Pace Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,937 shares of NPCE stock, worth $24,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,937
Previous 2,707
28.44%
Holding current value
$24,871
Previous $30,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NPCE
# of Institutions
85Shares Held
24.6MCall Options Held
20.2KPut Options Held
21.9K-
Polar Capital Holdings PLC London, X03.1MShares$39.8 Million0.17% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$38 Million1.88% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.61MShares$33.6 Million0.93% of portfolio
-
Morgan Stanley New York, NY2.55MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$18.4 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $319M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...